DarioHealth (DRIO) to Release Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is scheduled to issue its quarterly earnings data before the market opens on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

DarioHealth (NASDAQ:DRIO) last issued its earnings results on Wednesday, May 15th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.39. The company had revenue of $5.76 million during the quarter, compared to the consensus estimate of $5.95 million. DarioHealth had a negative net margin of 282.38% and a negative return on equity of 76.11%. On average, analysts expect DarioHealth to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

DarioHealth Price Performance

NASDAQ:DRIO traded up $0.01 on Tuesday, reaching $0.98. 40,291 shares of the company’s stock traded hands, compared to its average volume of 123,297. The firm has a market cap of $29.32 million, a PE ratio of -0.52 and a beta of 1.53. The company has a quick ratio of 2.67, a current ratio of 2.95 and a debt-to-equity ratio of 0.31. The stock has a 50-day simple moving average of $1.24 and a 200-day simple moving average of $1.56. DarioHealth has a 12 month low of $0.68 and a 12 month high of $3.55.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.